Medicamentos de actualidad = Drugs of today

• 

  Año 2021, Vol. 57, Número 6

  • MONOGRAPHS

    • An update on atezolizumab for hepatocellular carcinoma

      Luca Ielasi, Vito Sansone, Antonella Forgione, Alessandro Granito, Francesca Benevento, Francesco Tovoli

      • Resumen

      págs. 365-375

      

    • Lurbinectedin for the treatment of small cell lung cancer

      Jun Li, Chang Zou, Shaowei Dong, Zhuoxun Wu, Charles R. Ashby, Jr., Zhe-Sheng Chen, Chen Qiu

      • Resumen

      págs. 377-385

      

    • Onasemnogene abeparvovec-xioi:: a gene replacement strategy for the treatment of infants diagnosed with spinal muscular atrophy.

      M. Schwartz, Shibi Likhite, Kathrin Meyer

      • Resumen

      págs. 387-399

      

  • MEETING REPORT

    • MedTech Forum 2021 (April 20-22, 2021 – Virtual Meeting).

      Monica Colina

      • Resumen

      págs. 401-405

      

  • NEW PRODUCT INTROS

    • New product intros [anamorelin hydrochloride, casimersen, loncastuximab tesirine, dapagliflozin (new indication), molidustat sodium, mometasone furoate/azelastine hydrochloride (new combination), OTL-200, setmelanotide, umbralisib tosylate (first-in-class), vericiguat].

      págs. 407-411